Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Investing

Eli Lilly : LLY

All Eli Lilly Articles

624 Articles

Rich Duprey | Dec 28, 2025 at 7:29 AM EST

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026

Dividend growth investing builds long-term wealth for retirement by focusing on companies that consistently increase payouts. These stocks provide rising…

Rich Duprey | Dec 19, 2025 at 10:52 AM EST

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Eli Lilly (NYSE:LLY | LLY Price Prediction) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss.…

Omor Ibne Ehsan | Dec 17, 2025 at 10:05 AM EST

Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly

Very few investors can match Stanley Druckenmiller. He delivered an average annual return of over 30% over three decades at…

Lee Jackson | Dec 16, 2025 at 8:09 AM EST

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Pre-Market Stock Futures: The futures are trading lower after what started as a bounce-back Monday turned into a reversal Monday,…

Ian Cooper | Dec 11, 2025 at 10:44 AM EST

Stock Market Live December 11, 2025: S&P 500 (SPY) in the Red After Nearing Record Highs

Just yesterday, markets celebrated the latest quarter-point cut from the Federal Reserve, which lowered rates to a range of 3.5%…

William Temple | Dec 8, 2025 at 8:21 AM EST

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two…

Ian Cooper | Dec 2, 2025 at 10:30 AM EST

Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple

After a rough pullback, the major indices are attempting to rebound higher. Helping, not only is Bitcoin starting to rebound,…

Ian Cooper | Dec 2, 2025 at 9:20 AM EST

Stock Market Live December 2: S&P 500 (SPY) Rebounding with Tech

After a rough pullback, the major indices are attempting to rebound higher. At the moment, S&P 500 futures are up…

Rich Duprey | Nov 15, 2025 at 8:00 AM EST

Alphabet’s Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too?

Alphabet (NASDAQ:GOOG | GOOG Price Prediction)(NASDAQ:GOOGL) dominates the search engine market with a greater than 90% share, powering billions of…

Douglas A. McIntyre | Nov 14, 2025 at 4:13 PM EST

Retail Investors Really Don’t Like Novo Nordisk (NVO) Stock

Shares of Novo Nordisk A/S (NYSE: NVO | NVO Price Prediction) dropped 1.9%today, closing at $48.25, just a whisker above…

Ian Cooper | Nov 10, 2025 at 12:45 PM EST

Wall Street is Pounding the Table Over NVDA, RUN, LLY

Markets are coming back strong. All thanks to the news that the government shutdown may soon be over, which would…

Lee Jackson | Nov 10, 2025 at 8:11 AM EST

Here Are Monday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More

Pre-Market Stock Futures: The futures are trading higher as the new week begins, with most investors and traders relieved that…

Rich Duprey | Nov 3, 2025 at 10:13 AM EST

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments that…

Joel South | Oct 30, 2025 at 9:25 AM EDT

Eli Lilly Blows Away Q3 Earnings Expectations

Eli Lilly (NYSE: LLY | LLY Price Prediction) delivered a commanding third quarter, posting earnings and revenue that significantly exceeded…

Rich Duprey | Oct 17, 2025 at 11:05 AM EDT

Is Trump Going to Kill the GLP-1 Cash Cow?

The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and diabetes treatments into massive…

1 2 3 4 5 6 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Stock Market Live December 11, 2025: S&P 500 (SPY) in the Red After Nearing Record Highs

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple

Stock Market Live December 2: S&P 500 (SPY) Rebounding with Tech

Alphabet’s Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too?

Retail Investors Really Don’t Like Novo Nordisk (NVO) Stock

Wall Street is Pounding the Table Over NVDA, RUN, LLY

Here Are Monday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

Eli Lilly Blows Away Q3 Earnings Expectations

Is Trump Going to Kill the GLP-1 Cash Cow?

Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Live Nasdaq Composite: Bulls Keep Control on Tech Deals, Chip Profit Growth and Easing Oil

Live: Will Axon Deliver Another Blowout Quarter After the Bell?

Ford Exits EVs As Toyota Move In

26-Year-Old Trader Investing 20% While Carrying $20K Debt: Here’s Why the Math Doesn’t Work

Super Micro Doubled Revenue Year Over Year, and the Stock Is Still Flat. That Math Doesn’t Add Up

26-Year-Old Trader Investing 20% While Carrying $20K Debt: Here's Why the Math Doesn't Work

How to Build $2,000 a Month in Dividend Income

Which Oil and Gas Stock Has Dominated in 2026: Occidental Petroleum, ConocoPhillips, or EOG Resources?

USO and BNO Have Soared 100% Plus in 2026, Here’s the Better Pick for Next

Eli Lilly : LLY

All Eli Lilly Articles

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Stock Market Live December 11, 2025: S&P 500 (SPY) in the Red After Nearing Record Highs

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple

Stock Market Live December 2: S&P 500 (SPY) Rebounding with Tech

Alphabet’s Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too?

Retail Investors Really Don’t Like Novo Nordisk (NVO) Stock

Wall Street is Pounding the Table Over NVDA, RUN, LLY

Here Are Monday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

Eli Lilly Blows Away Q3 Earnings Expectations

Is Trump Going to Kill the GLP-1 Cash Cow?

Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Live Nasdaq Composite: Bulls Keep Control on Tech Deals, Chip Profit Growth and Easing Oil

Live: Will Axon Deliver Another Blowout Quarter After the Bell?

Ford Exits EVs As Toyota Move In

26-Year-Old Trader Investing 20% While Carrying $20K Debt: Here’s Why the Math Doesn’t Work

Super Micro Doubled Revenue Year Over Year, and the Stock Is Still Flat. That Math Doesn’t Add Up

Featured Reads

26-Year-Old Trader Investing 20% While Carrying $20K Debt: Here's Why the Math Doesn't Work

How to Build $2,000 a Month in Dividend Income